-
2
-
-
0036803121
-
Toxoplasma gondii: Transmission, diagnosis and prevention
-
Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8:634-640.
-
(2002)
Clin Microbiol Infect
, vol.8
, pp. 634-640
-
-
Hill, D.1
Dubey, J.P.2
-
3
-
-
0037463683
-
Trimethoprim-sulfamethoxazole revisited
-
Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 2003; 163:402-410.
-
(2003)
Arch Intern Med
, vol.163
, pp. 402-410
-
-
Masters, P.A.1
O'Bryan, T.A.2
Zurlo, J.3
Miller, D.Q.4
Joshi, N.5
-
4
-
-
42049118031
-
In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone
-
Meneceur P, Bouldouyre M-A, Aubert D, Villena I, Menotti J, Sauvage V, et al. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob Agents Chemother 2008; 52:1269-1277.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1269-1277
-
-
Meneceur, P.1
Bouldouyre, M.-A.2
Aubert, D.3
Villena, I.4
Menotti, J.5
Sauvage, V.6
-
5
-
-
0028317038
-
In vitro effects of artemisinin ether, cycloguanil, hydrochloride (alone and in combination of sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii
-
Holfels E, McCauley J, Mack D, Milhous WK, McLeod R. In vitro effects of artemisinin ether, cycloguanil, hydrochloride (alone and in combination of sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 1994; 38:1392-1396.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 1392-1396
-
-
Holfels, E.1
McCauley, J.2
Mack, D.3
Milhous, W.K.4
McLeod, R.5
-
6
-
-
1942501224
-
In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand
-
Chotivanich K, Udomsangpetch R, Chierakul W, Newton P, Ruangveerayuth R, Pukrittayakamee S, et al. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am J Trop Med Hyg 2004; 70:395-397.
-
(2004)
Am J Trop Med Hyg
, vol.70
, pp. 395-397
-
-
Chotivanich, K.1
Udomsangpetch, R.2
Chierakul, W.3
Newton, P.4
Ruangveerayuth, R.5
Pukrittayakamee, S.6
-
7
-
-
33748902120
-
Artesunate and artemether are effective fasciolicides in the rat model and in vitro
-
Keiser J, Shu-hua X, Tanner M, Utzinger J. Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J Antimicrob Chemother 2006; 57:1139-1145.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 1139-1145
-
-
Keiser, J.1
Shu-Hua, X.2
Tanner, M.3
Utzinger, J.4
-
9
-
-
57649222343
-
Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle
-
D'Angelo JG, Bordón C, Posner GH, Yolken R, Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother 2009; 63:146-150.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 146-150
-
-
D'Angelo, J.G.1
Bordón, C.2
Posner, G.H.3
Yolken, R.4
Jones-Brando, L.5
-
10
-
-
0034030445
-
Effects of artesunate, dihydroartemisinin and an artesunate-dihydroartemisinin combination against Toxoplasma gondii
-
Sarciron ME, Saccharin C, Petavy AF, Peyron P. Effects of artesunate, dihydroartemisinin and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg 2000; 62:73-76.
-
(2000)
Am J Trop Med Hyg
, vol.62
, pp. 73-76
-
-
Sarciron, M.E.1
Saccharin, C.2
Petavy, A.F.3
Peyron, P.4
-
11
-
-
59049099135
-
Effect of artesunate on Toxoplasma gondii: In vitro and in vivo studies
-
El Zawawy L. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies, J Egypt Soc Parasitol 2008; 38:185-201.
-
(2008)
J Egypt Soc Parasitol
, vol.38
, pp. 185-201
-
-
El Zawawy, L.1
-
12
-
-
51449116958
-
Artesunate: Developmental toxicity and toxicokinetics in monkeys
-
Clark RL, Arima A, Makori N, Nakata Y, Bernard F, Gristwood W. et al. Artesunate: developmental toxicity and toxicokinetics in monkeys. Birth Defects Res B Dev Reprod Toxicol 2008; 83:418-434.
-
(2008)
Birth Defects Res B Dev Reprod Toxicol
, vol.83
, pp. 418-434
-
-
Clark, R.L.1
Arima, A.2
Makori, N.3
Nakata, Y.4
Bernard, F.5
Gristwood, W.6
-
13
-
-
11344258568
-
Developmental toxicity of Artesunate and an Artesunate combination in the rat and rabbit
-
Clark RL, White TE, A Clode S, Gaunt I, Winstanley P, Ward SA. Developmental toxicity of Artesunate and an Artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 2004; 71:380-394.
-
(2004)
Birth Defects Res B Dev Reprod Toxicol
, vol.71
, pp. 380-394
-
-
Clark, R.L.1
White, T.E.2
Clode, S.A.3
Gaunt, I.4
Winstanley, P.5
Ward, S.A.6
-
14
-
-
0018758843
-
The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo
-
Grossman PL, Remington JS. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979; 28:445-455.
-
(1979)
Am J Trop Med Hyg
, vol.28
, pp. 445-455
-
-
Grossman, P.L.1
Remington, J.S.2
-
15
-
-
0032827171
-
Evaluation of trimethoprim and sulfamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models
-
Dumas J, Pizzolato G, Pechère J. Evaluation of trimethoprim and sulfamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models. Int J Antimicrob Agents. 1999; 13:35-39.
-
(1999)
Int J Antimicrob Agents
, vol.13
, pp. 35-39
-
-
Dumas, J.1
Pizzolato, G.2
Pechère, J.3
-
16
-
-
27644587827
-
Prospective Randomized Trial of Trimethoprim/Sulfamethoxazole versus Pyrimethamine and Sulfadiazine in the Treatment of Ocular Toxoplasmosis
-
Soheilian M, Sadoughi M-M, Ghajamia M, Dehghan MH, Yazdani S, Behboudi H, et al. Prospective Randomized Trial of Trimethoprim/Sulfamethoxazole versus Pyrimethamine and Sulfadiazine in the Treatment of Ocular Toxoplasmosis. Ophthalmology 2005; 112:1876-1882.
-
(2005)
Ophthalmology
, vol.112
, pp. 1876-1882
-
-
Soheilian, M.1
Sadoughi, M.-M.2
Ghajamia, M.3
Dehghan, M.H.4
Yazdani, S.5
Behboudi, H.6
-
17
-
-
0025879616
-
Activity of Pentamidine and Pentamidine analogs against Toxoplasma gondii in cell cultures
-
Lindsay DS, Blagburn BL, Hall JE, Tidwell RR. Activity of Pentamidine and Pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrob Agents Chemother 1991; 35:1914-1916.
-
(1991)
Antimicrob Agents Chemother
, vol.35
, pp. 1914-1916
-
-
Lindsay, D.S.1
Blagburn, B.L.2
Hall, J.E.3
Tidwell, R.R.4
-
18
-
-
0024439666
-
In vitro effects of folate inhibitors on Toxoplasma gondii
-
Derouin F, Chastang C. In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob Agents Chemother 1989; 33:1753-1759.
-
(1989)
Antimicrob Agents Chemother
, vol.33
, pp. 1753-1759
-
-
Derouin, F.1
Chastang, C.2
-
19
-
-
0027259369
-
In vitro evaluation of the activities of Azithromycin alone and combined with Pyrimethamine against Toxoplasma gondii
-
Cantin L, Chamberland S. In vitro evaluation of the activities of Azithromycin alone and combined with Pyrimethamine against Toxoplasma gondii. Antimicrob Agents Chemother 1993; 37:1993-1996.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 1993-1996
-
-
Cantin, L.1
Chamberland, S.2
-
20
-
-
0030178788
-
Anti-oxoplasma effects of pyrimethamine, trimethoprim and sulphonamides alone and in combination: Implications for therapy
-
Ven A, Ven E, Camps W, Melchers W, Koopmans P, Meer J, et al. Anti-oxoplasma effects of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy. J Ant Chemother 1996; 38:75-80.
-
(1996)
J Ant Chemother
, vol.38
, pp. 75-80
-
-
Ven, A.1
Ven, E.2
Camps, W.3
Melchers, W.4
Koopmans, P.5
Meer, J.6
|